NASDAQ:MRNA
Moderna Stock News
$141.01
+8.11 (+6.10%)
At Close: May 20, 2024
Moderna Stock Surges on Optimism of Bringing More Products to Market
02:50pm, Tuesday, 02'nd Jan 2024
Moderna Inc. (MRNA) shares soared 15% Tuesday as the vaccine maker got two pieces of positive news.
2 Major Reasons Why Moderna (MRNA) Stock Is Up Today
01:45pm, Tuesday, 02'nd Jan 2024
The biotech sector has been hit hard in recent years. Among the most disappointing stocks for growth investors in this space has certainly been Moderna (NASDAQ: MRNA ), an RNA-based vaccine maker that
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
01:32pm, Tuesday, 02'nd Jan 2024
The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot.
Moderna stock climbs on growth plans, broker upgrade
12:38pm, Tuesday, 02'nd Jan 2024
Moderna Inc shares shot up 14% to $113.72 in midday trading on Tuesday after the vaccine maker's CEO confirmed the company's goal of achieving sales growth in 2025. Brokerage firm Oppenheimer also
Midday Movers: Moderna Rises After an Upgrade, While Apple Falls Following Downgrade
12:20pm, Tuesday, 02'nd Jan 2024
U.S. equities began the first day of trading in 2024 mixed at midday, amid concerns over tech exports to China and naval military action in the Middle East. The Dow rose slightly, while the S&P 500 an
Moderna surges after CEO says sales growth expected in 2025
10:49am, Tuesday, 02'nd Jan 2024
Moderna shares rose more than 11% on Tuesday after the vaccine maker's CEO Stéphane Bancel said in a shareholder letter that the company expects its sales to grow in 2025.
Moderna's stock soars 10% to lead S&P 500 gainers as Oppenheimer upgrades to buy
10:46am, Tuesday, 02'nd Jan 2024
Moderna Inc.'s stock soared 10% Tuesday to lead S&P 500 index gainers, after Oppenheimer upgraded the stock to the equivalent of buy and said it expects the biotech to have five products approved by 2
Moderna Stock Starts 2024 With an Upgrade After a Terrible Year. Here's Why.
08:25am, Tuesday, 02'nd Jan 2024
The vaccine maker's shares tumbled 45% over the past 12 months, but Oppenheimer analysts can see a turning point.
Revealed: The most disappointing stocks of 2023
09:08am, Sunday, 31'st Dec 2023
The general stock market is concluding 2023 on a positive note, propelled by specific equities that have spearheaded an end-of-year rally. Significantly, these gains have enabled several stocks to rec
Why the Market Dipped But Moderna (MRNA) Gained Today
07:33pm, Friday, 29'th Dec 2023
In the latest trading session, Moderna (MRNA) closed at $99.45, marking a +0.67% move from the previous day.
Here are the 20 worst-performing stocks among the S&P 500 in 2023
11:18am, Friday, 29'th Dec 2023
The U.S. stock market staged a remarkable rally in 2023, but 173 stocks in the S&P 500 were still down for the year.
Moderna Stock Is Climbing Thanks to Merck, But Is It Still a Buy?
09:15am, Friday, 29'th Dec 2023
Merck and Moderna are teaming up to make an advanced oncology drug. The candidate's clinical trials are proceeding swimmingly.
S&P 500's Biggest Losers in 2023: Dollar General, Moderna, and More
12:12pm, Thursday, 28'th Dec 2023
The five worst performers in the market benchmark so far this year could be set for brighter futures.
The Winners and Losers: 2023 Stock Market Performance Review
12:25pm, Wednesday, 27'th Dec 2023
A 2023 stock market recap is a tale of highs and lows. We entered the year after a Fed tightening cycle proved restrictive but seemingly unsuccessful as inflation continued while rates rose.
Moderna and Pfizer Stock Tumbled in 2023. Wall Street Sees a Rebound.
11:47am, Wednesday, 27'th Dec 2023
Covid-19-vaccine makers Moderna and Pfizer saw shares drop in 2023, but analysts expect double-digit-percentage gains next year.
